The bacterial gut microbiome of probiotic-treated very-preterm infants: changes from admission to discharge

Jacob A F Westaway1,2, Roger Huerlimann3,4,5, Yoga Kandasamy6,7

  • 1College of Public Health, Medical and Veterinary Science, James Cook University, 1/14-88 McGregor Road, Smithfield, QLD, 4878, Australia. jacob.westaway@my.jcu.edu.au.

Pediatric Research
|October 8, 2021
PubMed

Insights

Probiotic treatment in preterm infants showed altered gut bacteria, with lower diversity linked to formula feeding and health issues like sepsis and ROP. This highlights the importance of a healthy gut microbiome for infant health.

Area of Science:

  • Microbiology
  • Neonatology
  • Gastroenterology

Background:

  • Preterm birth can disrupt gut microbiome development, increasing risks for acute and chronic diseases.
  • Probiotics may help correct microbial imbalances and reduce disease risk in premature infants.
  • Understanding the preterm infant gut microbiome is crucial for improving health outcomes.

Purpose of the Study:

  • To characterize the gut microbiome of probiotic-treated premature infants using amplicon sequencing.
  • To identify variations in bacterial gut flora from admission to discharge.
  • To associate gut microbiome composition with clinical variables in preterm infants.

Main Methods:

  • Recruited infants born <32 weeks gestation and <1500 g who received probiotic treatment.
  • Collected meconium and fecal samples at admission and discharge.
  • Performed 16S rRNA short amplicon sequencing and analyzed data using univariate and multivariate methods.

Main Results:

  • Significant changes in gut flora were observed from admission to discharge.
  • Lower alpha diversity was associated with sepsis, retinopathy of prematurity (ROP), and formula feeding.
  • Chorioamnionitis, preeclampsia, sepsis, necrotising enterocolitis, and ROP were linked to differential abundance of several bacterial taxa.

Conclusions:

  • Lower microbial diversity in formula-fed infants and those with diagnosed disorders underscores the microbiome's role in health and disease.
  • Differing bacterial abundances associated with various clinical factors highlight the impact of maternal and infant conditions on the gut microbiome.
  • This study supports the promotion of healthy gut microbiome development in preterm neonates.
Abstract

Related Concept Videos

Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
84.2K
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
754
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
31